These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5021396)

  • 21. [Higher fatty acids in liver and bile duct diseases in children].
    Alekseenko VP; Bliudzin IuA; Zviagina FE; Tarasova GG
    Vopr Okhr Materin Det; 1972 Oct; 17(10):28-32. PubMed ID: 4656405
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pathobiochemical aspects of interactions between glycoproteins and glycoprotein receptors].
    Köttgen E; Gerok W
    Med Welt; 1979 Jan; 30(1):20-9. PubMed ID: 759800
    [No Abstract]   [Full Text] [Related]  

  • 23. [Gamma-glutamyl-transpeptidase in certain internal diseases].
    Bednarzewski J; Rozek S
    Wiad Lek; 1966 Feb; 19(4):271-5. PubMed ID: 5946935
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bile electrolytes in patients with chronic diseases of the liver and bile ducts].
    Revutskiĭ BI; Shmakov VN; Nechaev EN
    Vrach Delo; 1969 Oct; 10():118-20. PubMed ID: 5366772
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metabolic capacity of the liver for drugs in hepatobiliary patients].
    González Macias J; Herreros Fernández V; De Castro Del Pozo S
    Rev Clin Esp; 1975 Jan; 136(2):123-30. PubMed ID: 1121588
    [No Abstract]   [Full Text] [Related]  

  • 26. [Properdin system and liver diseases].
    Reissmann G
    Z Gesamte Inn Med; 1970 Apr; 25(7):297-300. PubMed ID: 5521440
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum ceruloplasmin in hepatobiliary and other disorders: significance of abnormal values.
    Gault MH; Stein J; Aronoff A
    Gastroenterology; 1966 Jan; 50(1):8-18. PubMed ID: 5900960
    [No Abstract]   [Full Text] [Related]  

  • 28. In situ monitoring of caspase activation in hepatobiliary diseases.
    Bantel H; Ruck P; Schulze-Osthoff K
    Cell Death Differ; 2000 May; 7(5):504-5. PubMed ID: 10917736
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hyperlipidemia and hepatobiliary diseases].
    Naito C
    Rinsho Byori; 1970 Apr; 18(4):245-50. PubMed ID: 5463491
    [No Abstract]   [Full Text] [Related]  

  • 30. Lipids, lipoproteins, and cell membranes.
    Harry DS; Owen JS; McIntyre N
    Prog Liver Dis; 1982; 7():319-29. PubMed ID: 7051152
    [No Abstract]   [Full Text] [Related]  

  • 31. [The valve of the determination of the ornithine-carbamyl transferase in the serum and its comparison with the determination of the glutamo-pyruvic transaminase in clinical hepatology].
    Cachin M; Girard ML; Charbonnier A; Rousselet F; Koch M; Khoury K
    Pathol Biol; 1965 May; 13(9):477-88. PubMed ID: 5320274
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bile acids; their physiological role, clinical significance].
    Komarov FI; Ivanov AI
    Ter Arkh; 1972 Mar; 44(3):10-5. PubMed ID: 5027940
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lipoproteins in liver & biliary tract diseases].
    SZERESZEWSKA H; CHODERA L; PATELSKI J
    Pol Arch Med Wewn; 1957; 27(11):1511-24. PubMed ID: 13527287
    [No Abstract]   [Full Text] [Related]  

  • 34. [Circulation of ampicillin and sulfalene in liver disease patients].
    Iakovlev VP; Bobrov VI; Gal'perin EI; Volkova NV; Nazarova OI
    Antibiotiki; 1982 Aug; 27(8):619-23. PubMed ID: 7125622
    [No Abstract]   [Full Text] [Related]  

  • 35. [Abnormal blood lipoproteins in hepatobiliary pathology].
    Burstein M; Caroli J
    Rev Med Chir Mal Foie; 1969; 44(3):125-38. PubMed ID: 5385890
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipid and lipoprotein abnormalities in alcoholic liver disease.
    Sabesin SM
    Circulation; 1981 Sep; 64(3 Pt 2):III 72-84. PubMed ID: 7020988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum iron and copper levels and serum activity of phosphohexoisomerase and glutamic-pyruvic transaminase in patients with liver and biliary tract disease].
    Switlik I; Szymańska H; Myśliwicz-Rychlik H
    Pol Arch Med Wewn; 1966; 36(3):365-70. PubMed ID: 5941685
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in gamma-glutamyltransferase activity in diseases of the liver and biliary tract].
    Vŭrbanov G; Mikhova V; Gancheva D; Atanasova A
    Ter Arkh; 1993; 65(2):82-5. PubMed ID: 9133021
    [No Abstract]   [Full Text] [Related]  

  • 39. The clinical role of the bile acids in selected paediatric and surgical diseases.
    Polkowska G; Polkowski WP
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):407-10. PubMed ID: 15323227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activity of glutamic acid dehydrogenase in serum of patients with liver diseases].
    Hankiewicz J; Antes B
    Pol Arch Med Wewn; 1965; 35(6):767-70. PubMed ID: 5837283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.